Outstanding cancer care requires an unparalleled team. Our specialists in medical oncology, chemotherapy, radiation medicine, pathology and radiology all work and consult together to deliver you the most effective treatments.

Chemotherapy is one of the longest-used and most common treatments for neuroendocrine tumors. In most cases, chemotherapy works by interfering with the tumor’s ability to grow and reproduce. For some types of tumors, chemotherapy may be used alone or in combination with other treatments, such as radiation or surgery. A combination of chemotherapy medicines is typically used to fight a specific cancer.

While chemotherapy can be quite effective in treating NETs, the medications reach all parts of the body, not just the tumorous cells. There can be many side effects during treatment and discussing these side effects with your care team before treatment can help you and your caregivers manage them effectively.

Radiation therapy is the most common treatment for NETs but is often used along with other treatments, such as surgery or chemotherapy. Your doctor may recommend radiation if it’s necessary to:

  • Shrink a tumor before surgery to make it easier to remove
  • Kill any remaining tumor cells following surgery
  • Relieve symptoms such as pain, bleeding, trouble swallowing, cough or problems caused by the tumor spreading

External beam radiation therapy is frequently used to treat NETs. This treatment focuses a beam of radiation on the tumor to eliminate cancerous cells.

Learn more about our services by visiting our Radiation Oncology website.

During surgery for an NET, surgeons remove the tumor and a small amount of surrounding healthy tissue. Patients have several surgical options, and the type of surgery can depend on a few factors, such as:

  • Your overall health
  • The type and stage of your tumor
  • The size of the tumor

Peptide receptor radionuclide therapy administers targeted radiation specifically to the tumor cells with the help of a radioactive pharmaceutical agent.

Markey Cancer Center is NCI-designated

The UK Markey Cancer Center was first designated by the National Cancer Institute in 2013 – a distinction that recognizes our extraordinary ability to provide world-class care for our patients. We are the only NCI-designated cancer center in Kentucky and one of only 71 in the nation.

LEARN MORE